{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:57:48Z","timestamp":1776164268536,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"DOI":"10.7759\/cureus.30024","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:37:43Z","timestamp":1665142663000},"source":"Crossref","is-referenced-by-count":3,"title":["Laser Treatment Modalities for Diabetic Retinopathy"],"prefix":"10.7759","author":[{"given":"Gauri S","family":"Pande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Tidake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diabetic retinopathy (treatment)","volume":"2011","author":"Mohamed QA","year":"2011","unstructured":"Mohamed QA, Ross A, Chu CJ. Diabetic retinopathy (treatment). BMJ Clin Evid. 2011, 2011:0702.","journal-title":"BMJ Clin Evid"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03756.x","article-title":"Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review","volume":"30","author":"Burgess PI","year":"2013","unstructured":"Burgess PI, MacCormick IJ, Harding SP, Bastawrous A, Beare NA, Garner P. Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review. Diabet Med. 2013, 30:399-412. 10.1111\/j.1464-5491.2012.03756.x","journal-title":"Diabet Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaitpost.2017.08.022","article-title":"Clinical measures of balance in people with type two diabetes: a systematic literature review","volume":"58","author":"Dixon CJ","year":"2017","unstructured":"Dixon CJ, Knight T, Binns E, Ihaka B, O'Brien D. Clinical measures of balance in people with type two diabetes: a systematic literature review. Gait Posture. 2017, 58:325-32. 10.1016\/j.gaitpost.2017.08.022","journal-title":"Gait Posture"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1694187","article-title":"Current advances in pharmacotherapy and technology for diabetic retinopathy: a systematic review","volume":"2018","author":"Lu L","year":"2018","unstructured":"Lu L, Jiang Y, Jaganathan R, Hao Y. Current advances in pharmacotherapy and technology for diabetic retinopathy: a systematic review. J Ophthalmol. 2018, 2018:1694187. 10.1155\/2018\/1694187","journal-title":"J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012314.pub2","article-title":"Different lasers and techniques for proliferative diabetic retinopathy","volume":"3","author":"Moutray T","year":"2018","unstructured":"Moutray T, Evans JR, Lois N, Armstrong DJ, Peto T, Azuara-Blanco A. Different lasers and techniques for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2018, 3:CD012314. 10.1002\/14651858.CD012314.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2018.12.923","article-title":"Panretinal photocoagulation plus Intravitreal Bevacizumab versus Panretinal photocoagulation alone for proliferative diabetic retinopathy","volume":"28","author":"Ali W","year":"2018","unstructured":"Ali W, Abbasi KZ, Raza A. Panretinal photocoagulation plus Intravitreal Bevacizumab versus Panretinal photocoagulation alone for proliferative diabetic retinopathy. J Coll Physicians Surg Pak. 2018, 28:923-7. 10.29271\/jcpsp.2018.12.923","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3310\/hta13600","article-title":"Colour vision testing for diabetic retinopathy: a systematic review of diagnostic accuracy and economic evaluation","volume":"13","author":"Rodgers M","year":"2009","unstructured":"Rodgers M, Hodges R, Hawkins J, et al.. Colour vision testing for diabetic retinopathy: a systematic review of diagnostic accuracy and economic evaluation. Health Technol Assess. 2009, 13:1-160. 10.3310\/hta13600","journal-title":"Health Technol Assess"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102309","article-title":"Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis","volume":"9","author":"R\u00e9gnier S","year":"2014","unstructured":"R\u00e9gnier S, Malcolm W, Allen F, Wright J, Bezlyak V. Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis. PLoS One. 2014, 9:e102309. 10.1371\/journal.pone.0102309","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2014-305938","article-title":"Extending the diabetic retinopathy screening interval beyond 1 year: systematic review","volume":"100","author":"Taylor-Phillips S","year":"2016","unstructured":"Taylor-Phillips S, Mistry H, Leslie R, Todkill D, Tsertsvadze A, Connock M, Clarke A. Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol. 2016, 100:105-14.","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0079","article-title":"Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies","volume":"34","author":"Kramer CK","year":"2011","unstructured":"Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care. 2011, 34:1238-44. 10.2337\/dc11-0079","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-593","article-title":"Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review","volume":"7","author":"James S","year":"2014","unstructured":"James S, Gallagher R, Dunbabin J, Perry L. Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review. BMC Res Notes. 2014, 7:593. 10.1186\/1756-0500-7-593","journal-title":"BMC Res Notes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709501","article-title":"Efficacy and safety of various treatments for proliferative diabetic retinopathy: a systematic review and network meta-analysis","volume":"12","author":"Zhang B","year":"2021","unstructured":"Zhang B, Zhou Z, Zhang B, Wang D. Efficacy and safety of various treatments for proliferative diabetic retinopathy: a systematic review and network meta-analysis. Front Pharmacol. 2021, 12:709501. 10.3389\/fphar.2021.709501","journal-title":"Front Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000499541","article-title":"Diabetic retinopathy in the context of patients with diabetes","volume":"62","author":"Sim\u00f3-Servat O","year":"2019","unstructured":"Sim\u00f3-Servat O, Hern\u00e1ndez C, Sim\u00f3 R. Diabetic retinopathy in the context of patients with diabetes. Ophthalmic Res. 2019, 62:211-7. 10.1159\/000499541","journal-title":"Ophthalmic Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3310\/hta19510","article-title":"Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation","volume":"19","author":"Royle P","year":"2015","unstructured":"Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, Waugh N. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Health Technol Assess. 2015, 19:v-xxviii, 1-247. 10.3310\/hta19510","journal-title":"Health Technol Assess"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2020.030502","article-title":"Inflammatory and angiogenic biomarkers in diabetic retinopathy","volume":"30","author":"Ka\u0161telan S","year":"2020","unstructured":"Ka\u0161telan S, Ore\u0161kovi\u0107 I, Bi\u0161\u0107an F, Ka\u0161telan H, Gverovi\u0107 Antunica A. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (Zagreb). 2020, 30:030502. 10.11613\/BM.2020.030502","journal-title":"Biochem Med (Zagreb)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma201913503155","article-title":"Clinical features of diabetic retinopathy in pregnancy (Article in Russian)","volume":"135","author":"Pomytkina NV","year":"2019","unstructured":"Pomytkina NV, Sorokin EL. Clinical features of diabetic retinopathy in pregnancy (Article in Russian). Vestn Oftalmol. 2019, 135:55-66. 10.17116\/oftalma201913503155","journal-title":"Vestn Oftalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2010.0075","article-title":"Diabetic retinopathy: early diagnosis and effective treatment","volume":"107","author":"Kollias AN","year":"2010","unstructured":"Kollias AN, Ulbig MW. Diabetic retinopathy: early diagnosis and effective treatment. Dtsch Arztebl Int. 2010, 107:75-83. 10.3238\/arztebl.2010.0075","journal-title":"Dtsch Arztebl Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13894","article-title":"Imbalances in tissue inhibitors of metalloproteinases differentiate choroidal neovascularization from geographic atrophy","volume":"97","author":"Krogh Nielsen M","year":"2019","unstructured":"Krogh Nielsen M, Subhi Y, Rue Molbech C, Nilsson LL, Nissen MH, S\u00f8rensen TL. Imbalances in tissue inhibitors of metalloproteinases differentiate choroidal neovascularization from geographic atrophy. Acta Ophthalmol. 2019, 97:84-90. 10.1111\/aos.13894","journal-title":"Acta Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13229","article-title":"Retinal oximetry in patients with ischaemic retinal diseases","volume":"95","author":"Rilv\u00e9n S","year":"2017","unstructured":"Rilv\u00e9n S, Torp TL, Grauslund J. Retinal oximetry in patients with ischaemic retinal diseases. Acta Ophthalmol. 2017, 95:119-27. 10.1111\/aos.13229","journal-title":"Acta Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.807687","article-title":"Effectiveness of panretinal photocoagulation plus intravitreal anti-VEGF treatment against PRP alone for diabetic retinopathy: a systematic review with meta-analysis","volume":"13","author":"Zhang W","year":"2022","unstructured":"Zhang W, Geng J, Sang A. Effectiveness of panretinal photocoagulation plus intravitreal anti-VEGF treatment against PRP alone for diabetic retinopathy: a systematic review with meta-analysis. Front Endocrinol (Lausanne). 2022, 13:807687. 10.3389\/fendo.2022.807687","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1851_19","article-title":"Assessment of diabetic retinopathy in type 1 diabetes in a diabetes care center in South India-feasibility and awareness improvement study","volume":"68","author":"Rajalakshmi R","year":"2020","unstructured":"Rajalakshmi R, Shanthirani CS, Anandakumar A, Anjana RM, Murthy GV, Gilbert C, Mohan V. Assessment of diabetic retinopathy in type 1 diabetes in a diabetes care center in South India-feasibility and awareness improvement study. Indian J Ophthalmol. 2020, 68:S92-5. 10.4103\/ijo.IJO_1851_19","journal-title":"Indian J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01677-6","article-title":"Functional assessment of early retinal changes in diabetic patients without clinical retinopathy using multifocal electroretinogram","volume":"20","author":"Mohammed MA","year":"2020","unstructured":"Mohammed MA, Lolah MM, Doheim MF, AbouSamra A. Functional assessment of early retinal changes in diabetic patients without clinical retinopathy using multifocal electroretinogram. BMC Ophthalmol. 2020, 20:411. 10.1186\/s12886-020-01677-6","journal-title":"BMC Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.9.40","article-title":"Enhancing risk assessment in patients with diabetic retinopathy by combining measures of retinal function and structure","volume":"9","author":"Brigell MG","year":"2020","unstructured":"Brigell MG, Chiang B, Maa AY, Davis CQ. Enhancing risk assessment in patients with diabetic retinopathy by combining measures of retinal function and structure. Transl Vis Sci Technol. 2020, 9:40. 10.1167\/tvst.9.9.40","journal-title":"Transl Vis Sci Technol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034699","article-title":"Evaluation of a hospital-based integrated model of eye care for diabetic retinopathy assessment: a multimethod study","volume":"10","author":"Long JC","year":"2020","unstructured":"Long JC, Blakely B, Mahmoud Z, et al.. Evaluation of a hospital-based integrated model of eye care for diabetic retinopathy assessment: a multimethod study. BMJ Open. 2020, 10:e034699. 10.1136\/bmjopen-2019-034699","journal-title":"BMJ Open"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011234.pub2","article-title":"Laser photocoagulation for proliferative diabetic retinopathy","volume":"11","author":"Evans JR","year":"2014","unstructured":"Evans JR, Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014, 11:CD011234. 10.1002\/14651858.CD011234.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010859.pub2","article-title":"Monotherapy laser photocoagulation for diabetic macular oedema","volume":"10","author":"Jorge EC","year":"2018","unstructured":"Jorge EC, Jorge EN, Botelho M, Farat JG, Virgili G, El Dib R. Monotherapy laser photocoagulation for diabetic macular oedema. Cochrane Database Syst Rev. 2018, 10:CD010859. 10.1002\/14651858.CD010859.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01657.x","article-title":"Steroid injection in addition to macular laser grid photocoagulation in diabetic macular oedema: a systematic review","volume":"88","author":"Steijns D","year":"2010","unstructured":"Steijns D, Duijvesz D, Breedijk MA, van der Heijden GJ. Steroid injection in addition to macular laser grid photocoagulation in diabetic macular oedema: a systematic review. Acta Ophthalmol. 2010, 88:389-93. 10.1111\/j.1755-3768.2009.01657.x","journal-title":"Acta Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010790.pub2","article-title":"Laser therapy for retinopathy in sickle cell disease","volume":"10","author":"Myint KT","year":"2015","unstructured":"Myint KT, Sahoo S, Thein AW, Moe S, Ni H. Laser therapy for retinopathy in sickle cell disease. Cochrane Database Syst Rev. 2015, 10:CD010790. 10.1002\/14651858.CD010790.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6634637","article-title":"Optical coherence tomography angiography of macular perfusion changes after anti-VEGF therapy for diabetic macular edema: a systematic review","volume":"2021","author":"Elnahry AG","year":"2021","unstructured":"Elnahry AG, Elnahry GA. Optical coherence tomography angiography of macular perfusion changes after anti-VEGF therapy for diabetic macular edema: a systematic review. J Diabetes Res. 2021, 2021:6634637. 10.1155\/2021\/6634637","journal-title":"J Diabetes Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2017.1353820","article-title":"Panretinal photocoagulation: a review of complications","volume":"33","author":"Reddy SV","year":"2018","unstructured":"Reddy SV, Husain D. Panretinal photocoagulation: a review of complications. Semin Ophthalmol. 2018, 33:83-8. 10.1080\/08820538.2017.1353820","journal-title":"Semin Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.17116\/oftalma2021137061110","article-title":"Internal ophthalmoplegia after retinal laser photocoagulation (Article in Russian)","volume":"137","author":"Veliyeva IA","year":"2021","unstructured":"Veliyeva IA. Internal ophthalmoplegia after retinal laser photocoagulation (Article in Russian). Vestn Oftalmol. 2021, 137:110-6. 10.17116\/oftalma2021137061110","journal-title":"Vestn Oftalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.01918.x","article-title":"Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema","volume":"89","author":"Yilmaz T","year":"2011","unstructured":"Yilmaz T, Cordero-Coma M, Gallagher MJ, Teasley LA. Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema. Acta Ophthalmol. 2011, 89:709-17. 10.1111\/j.1755-3768.2010.01918.x","journal-title":"Acta Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007419.pub5","article-title":"Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis","volume":"6","author":"Virgili G","year":"2017","unstructured":"Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database Syst Rev. 2017, 6:CD007419. 10.1002\/14651858.CD007419.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0615","article-title":"Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis","volume":"32","author":"Wong TY","year":"2009","unstructured":"Wong TY, Mwamburi M, Klein R, et al.. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009, 32:2307-13. 10.2337\/dc09-0615","journal-title":"Diabetes Care"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1240_18","article-title":"Diabetic macular edema: evidence-based management","volume":"66","author":"Browning DJ","year":"2018","unstructured":"Browning DJ, Stewart MW, Lee C. Diabetic macular edema: evidence-based management. Indian J Ophthalmol. 2018, 66:1736-50. 10.4103\/ijo.IJO_1240_18","journal-title":"Indian J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/108426-laser-treatment-modalities-for-diabetic-retinopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:26Z","timestamp":1707508166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/108426-laser-treatment-modalities-for-diabetic-retinopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.30024","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}